MF
MFGenie.ai
Sectoral / Thematic📊 BSE Healthcare Index (TRI)

HDFC Pharma and Healthcare Fund · Regular · Growth

HDFC Mutual Fund · Managed by Nikhil Mathur

#14 of 213 (1Y)

NAV

₹19.5570

as of 17 Jun 2026

Expense Ratio

2.09%

AUM

₹1,963 Cr

Viewing Regular · Growth
Compare Fund

Lumpsum returns (CAGR)

1Y
+18.64%
3Y
—
5Y
—
Since Inception
+28.17%

SIP returns (XIRR)

1Y
+24.99%
3Y
—
5Y
—
Since Inception
+21.98%

Beat the benchmark — ₹100/month SIP

Same SIP in this fund vs the benchmark index

This fund

₹4,192

Benchmark

₹3,767

+₹425 extra wealth vs the benchmark index

Backtest this SIP yourself

SIP since inception — what ₹100/month became

Real NAV backtest from day one

₹3,200

Invested

₹4,192

Value today

21.6%

XIRR (p.a.)

₹100/month SIP from fund inception · Current value as of today

Try SIP Calculator with this fund's history

₹100 lumpsum at launch — value today

Invested on the fund's first NAV date

₹100

Invested

₹195

Value today

28.3%

CAGR (p.a.)

One-time investment at fund inception · Growth purely from NAV appreciation

Try Lumpsum Calculator

₹6L corpus via 12-month STP from a liquid fund at inception

₹50K/month transferred from HDFC Liquid → this fund at launch

₹6,00,000

Invested

₹9,95,838

Value today

-15.1%

vs lumpsum

Direct lumpsum would have beaten STP by 15.1% — but STP reduced timing risk

Model your own STP with real NAV

Risk Metrics

Trailing 1 year, annualised

0.42

Sharpe Ratio

+0.11

Alpha

0.36

Beta

0.38

Sortino

15.63%

Std Dev

-15.07%

Max Drawdown

Performance Comparison

Thinking about HDFC Pharma and Healthcare Fund · Regular · Growth?

Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.

+91

By submitting, you agree to our Privacy Policy. No spam, ever.

Compare with Similar Funds

Nippon India Pharma Fund · Regular · Growth

3Y: +20.47%AUM: ₹8,116 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth

3Y: +25.33%AUM: ₹6,565 Cr

Tata India Pharma and Healthcare Fund · Regular · Growth

3Y: +20.99%AUM: ₹1,278 Cr

Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth

3Y: +22.12%AUM: ₹843 Cr

ITI Pharma and Healthcare Fund · Regular · Growth

3Y: +18.25%AUM: ₹217 Cr
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds

Fund Details

Fund HouseHDFC Mutual Fund
CategorySectoral / Thematic
Fund ManagerNikhil Mathur
BenchmarkBSE Healthcare Index (TRI) ✓
Launch Date14 Sept 2023
AMFI Code152084
Transaction facts
Min. Lumpsum₹100
Min. SIP₹100
Exit LoadIn respect of each purchase switch in of units an Exit load of 1% is payable if units are redeemed switched out within 30 days from the date of allotment No Exit Load is payable if units are redeemed switched out after 30 days from the date of allotment

Available transactions

PurchaseSIPRedeemSWPSwitchSTPDemat

Portfolio holdings

as of 30 Apr 2026
Holding% NAV

Investment Objective

HDFC Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.

About This Fund

HDFC Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by HDFC Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹1,963 Cr, reflecting investor confidence in the fund's strategy. The fund is managed by Nikhil Mathur. It benchmarks its performance against BSE Healthcare Index (TRI). The current expense ratio is 2.09%.

Who Should Invest?

  • •Investors with a high risk appetite seeking long-term wealth creation
  • •Investors with an investment horizon of 5 years or more
  • •SIP investors who can benefit from rupee cost averaging during market fluctuations